Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination.
Asinex 1
Cangrelor
G-protein coupled receptors
GPR17
SPR
ligand binding
Journal
Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
10
2019
accepted:
16
12
2019
entrez:
31
1
2020
pubmed:
31
1
2020
medline:
31
1
2020
Statut:
epublish
Résumé
The aim of this study was to investigate the potential of surface plasmon resonance (SPR) spectroscopy for the measurement of real-time ligand-binding affinities and kinetic parameters for GPR17, a G protein-coupled receptor (GPCR) of major interest in medicinal chemistry as potential target in demyelinating diseases. The receptor was directly captured, in a single-step, from solubilized membrane extracts on the sensor chip through a covalently bound anti-6x-His-antibody and retained its ligand binding activity for over 24 h. Furthermore, our experimental setup made possible, after a mild regeneration step, to remove the bound receptor without damaging the antibody, and thus to reuse many times the same chip. Two engineered variants of GPR17, designed for crystallographic studies, were expressed in insect cells, extracted from crude membranes and analyzed for their binding with two high affinity ligands: the antagonist Cangrelor and the agonist Asinex 1. The calculated kinetic parameters and binding constants of ligands were in good agreement with those reported from activity assays and highlighted a possible functional role of the N-terminal residues of the receptor in ligand recognition and binding. Validation of SPR results was obtained by docking and molecular dynamics of GPR17-ligands interactions and by functional
Identifiants
pubmed: 31998697
doi: 10.3389/fchem.2019.00910
pmc: PMC6966494
doi:
Types de publication
Journal Article
Langues
eng
Pagination
910Informations de copyright
Copyright © 2020 Capelli, Parravicini, Pochetti, Montanari, Temporini, Rabuffetti, Trincavelli, Daniele, Fumagalli, Saporiti, Bonfanti, Abbracchio, Eberini, Ceruti, Calleri and Capaldi.
Références
Cell Signal. 2014 Dec;26(12):2614-20
pubmed: 25152366
PLoS One. 2014 Aug 11;9(8):e104822
pubmed: 25111804
Crit Rev Anal Chem. 2015;45(2):97-105
pubmed: 25558771
Pharmacol Ther. 2010 Dec;128(3):387-418
pubmed: 20705094
Science. 2010 Nov 19;330(6007):1066-71
pubmed: 20929726
Nature. 2015 Apr 16;520(7547):317-21
pubmed: 25822790
Life Sci. 2019 May 1;224:33-40
pubmed: 30904492
J Comput Aided Mol Des. 2011 Aug;25(8):743-52
pubmed: 21744154
Mol Pharmacol. 2015 Sep;88(3):536-51
pubmed: 26152196
Protein Sci. 2017 Aug;26(8):1493-1504
pubmed: 28547763
Biochim Biophys Acta. 2013 Nov;1828(11):2583-91
pubmed: 23871992
J Med Chem. 2000 May 18;43(10):1986-92
pubmed: 10821711
Anal Biochem. 2010 Oct 15;405(2):153-9
pubmed: 20599649
Cell Death Dis. 2017 Jun 8;8(6):e2871
pubmed: 28594400
Biotechnol J. 2009 Nov;4(11):1542-58
pubmed: 19918786
Glia. 2015 Dec;63(12):2327-39
pubmed: 26228571
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Biochim Biophys Acta. 2014 Jan;1838(1 Pt A):43-55
pubmed: 23665295
Anal Biochem. 2011 Feb 15;409(2):267-72
pubmed: 20969829
Drug Discov Today. 2019 Nov;24(11):2192-2201
pubmed: 31520747
Biochim Biophys Acta. 2015 May;1848(5):1224-33
pubmed: 25725488
EMBO J. 2006 Oct 4;25(19):4615-27
pubmed: 16990797
Pharmacol Rev. 2006 Sep;58(3):281-341
pubmed: 16968944
PLoS One. 2017 Nov 3;12(11):e0182640
pubmed: 29099834
Anal Biochem. 2002 Jan 15;300(2):132-8
pubmed: 11779103
FEBS Lett. 2014 Dec 20;588(24):4701-7
pubmed: 25447525
J Med Chem. 2010 May 13;53(9):3489-501
pubmed: 20394377
Nature. 2012 May 16;485(7398):400-4
pubmed: 22596164
Science. 2007 Nov 23;318(5854):1258-65
pubmed: 17962520
Anal Biochem. 2011 Jan 1;408(1):46-52
pubmed: 20804721
Methods Enzymol. 2011;493:115-36
pubmed: 21371589
Science. 2007 Nov 23;318(5854):1266-73
pubmed: 17962519
J Biol Chem. 2011 Mar 25;286(12):10593-604
pubmed: 21209081
J Mol Graph Model. 2008 Feb;26(6):1004-13
pubmed: 17905618
Life Sci. 2003 Dec 12;74(4):489-508
pubmed: 14609727
BMC Struct Biol. 2010 Mar 16;10:8
pubmed: 20233425
Neuropharmacology. 2016 May;104:82-93
pubmed: 26453964
Front Pharmacol. 2015 Mar 31;6:66
pubmed: 25873898
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
pubmed: 21890895
Trends Biochem Sci. 1998 Apr;23(4):149-50
pubmed: 9584619
J Neurosci. 2017 Mar 1;37(9):2273-2275
pubmed: 28250056
BMC Bioinformatics. 2008 Jun 04;9:263
pubmed: 18533035
BMC Bioinformatics. 2012 Mar 28;13 Suppl 4:S1
pubmed: 22536955
Nature. 2012 Dec 20;492(7429):387-92
pubmed: 23222541
J Chem Inf Model. 2007 Jan-Feb;47(1):122-33
pubmed: 17238257
Methods Enzymol. 2015;556:499-525
pubmed: 25857797
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
AIMS Biophys. 2017;4(3):491-527
pubmed: 29951585
Sci Rep. 2014 Dec 08;4:7360
pubmed: 25484112
Cell Signal. 2016 Jun;28(6):631-42
pubmed: 26971834
Nature. 2014 May 1;509(7498):119-22
pubmed: 24784220